$22.77
N/A
Last update: Nov 5, 9:25 AM
Legend Biotech Corp
LEGNNASDAQ
The average analyst price target for Legend Biotech is $63.90, 180.6% above the current price. Of 15 analysts, 11 rate it Buy and 4 Hold. Targets range from $24 to $90. The latest change came on Oct 13, 2026, when Barclays lowered its price target on Legend Biotech from $74 to $68 and kept an Overweight rating.
Price Target Range — 12 Quarters
Analyst Consensus — 15 Analysts
Rating Trend — Last 9 Months
